MENU
GIFLF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Grifols Sa (GIFLF) Ownership - Who owns Grifols Sa?

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more

Profile

Industry
N/A
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
8.92B
P/E Ratio
26.97
Total Cash
565.8M
Projected Growth
0.24
Total Debt
8.82B
Revenue
7.45B
Risk (Beta)
0.95
Dividend Yield
0.01
Total Cash/Share
0.83
Total Debt/Equity
N/A
Revenue/Share
13.27 USD as % of share price

Fundamentals

GIFLF
Capitalization
8.92B
P/E Ratio
26.97
Risk (Beta)
0.95
Dividend Yield
0.01
Total Cash
566M
Total Cash/Share
0.83
Total Debt
8.82B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.24
Revenue/Share (as % of the share price)
13.27%
Revenue
7.45B
ROE
N/A
Book Value
5.17B
P/B Ratio
1.56
Cash Flow
N/A
Earnings
0.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
120M
Current Ratio
2.64
Current Revenue Per Employee
79459.29
Dividends Per Share - Security
0.00
EBITDA
1.62B
Float
N/A
Float - Current
N/A
Gross Income Margin
39.33
Revenue To Assets
1.41
Shares Held By Institutions
2.1B
Shares Outstanding - Current
681M
Total Liabilities
12.2B
Total Volume MTD
N/A
Value
1
Gain YTD
45.550
View a ticker or compare two or three
GIFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com